12:00 AM
 | 
Jan 16, 2012
 |  BC Week In Review  |  Company News  |  Deals

Gilead, Pharmasset deal

Gilead completed its tender offer for HCV company Pharmasset, acquiring about 72 million shares (95%) for $137...

Read the full 61 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >